Universitätsklinikum Tübingen

Erratum to: DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases (2015) Budach W, Matuschek C, Boelke E, Dunst J, Feyer P, Fietkau R, Haase W, et al. Journal article Immunotherapy of uveal melanoma: vaccination against cancer : Multicenter adjuvant phase 3 vaccination study using dendritic cells laden with tumor RNA for large newly diagnosed uveal melanoma (2015) Schuler-Thurner B, Bartz-Schmidt KU, Bornfeld N, Cursiefen C, Fuisting B, Grisanti S, Heindl LM, et al. Journal article DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases (2015) Budach W, Matuschek C, Bölke E, Dunst J, Feyer P, Fietkau R, Haase W, et al. Journal article Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML (2015) Fabarius A, Kalmanti L, Dietz CT, Lauseker M, Rinaldetti S, Haferlach C, Goehring G, et al. Journal article Acute respiratory and renal failure in a 20-year-old man (2015) Heissner K, Riessen R, Horger M, Amann KU, Haap M Journal article 443 paediatric cases of malignant melanoma registered with the German Central Malignant Melanoma Registry between 1983 and 2011 (2015) Brecht IB, Garbe C, Gefeller O, Pfahlberg A, Bauer J, Eigentler TK, Offenmüller S, et al. Journal article Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patients (2015) Hecht M, Zimmer L, Loquai C, Weishaupt C, Gutzmer R, Schuster B, Gleisner S, et al. Journal article Human Placenta-Derived CD146-Positive Mesenchymal Stromal Cells Display a Distinct Osteogenic Differentiation Potential (2015) Ulrich C, Abruzzese T, Maerz JK, Ruh M, Amend B, Benz K, Rolauffs B, et al. Journal article Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial (2015) Erber R, Gluz O, Brünner N, Kreipe HH, Pelz E, Kates R, Bartels A, et al. Journal article Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV (2015) Kalmanti L, Saussele S, Lauseker M, Mueller MC, Dietz CT, Heinrich L, Hanfstein B, et al. Journal article